Celexa and Celexa® is a selective serotonin reuptake inhibitor (SSRI) medication used to treat major depressive disorder and generalized anxiety disorder. It works by increasing the amount of serotonin available in the brain.
Celexa is a selective serotonin reuptake inhibitor (SSRI) medication that belongs to a class of drugs called “serotonin-norepinephrine reuptake inhibitors.”
While Celexa is generally well-tolerated, it may cause some side effects when combined with other medications or medical treatments. Common side effects may include:
Celexa should be taken exactly as prescribed by a healthcare professional. It can be taken with or without food. Swallow the tablet whole. Do not split or chew the tablet.
Alternate Name:CeleXA
Description:Celexa is prescribed for the treatment of depression. The generic version of Celexa is Citalopram. On average Celexa is priced at about $325 for a supply of 30, 20 mg tablets. Luckily, you can use our LowerMyRx savings offer to receive a Celexa discount of up to 80% off the retail price at participating pharmacies near you.
Dosage Form:Tablet
Administration Route:By mouth
Drug Class:Antidepressant
Generic Available:Yes
Strength:20 MG
Warnings:Tell your doctor if you are pregnant or breastfeeding, or if you have kidney disease, liver disease, bleeding problems, glaucoma, electrolyte imbalance, heart problems, sexual problems, or a seizure disorder. Tell your doctor if you or anyone in your family has a bipolar disorder, heart rhythm problem (including QT prolongation or a slow heartbeat), or a recent heart attack. For some children, teenagers, and young adults, this medicine may increase mental or emotional problems. This may lead to thoughts of suicide and violence. Talk with your doctor right away if you have any thoughts or behavior changes that concern you. Tell your doctor if you or anyone in your family has a history of bipolar disorder or suicide attempts. This medicine may cause the following problems: Heart rhythm problemsSerotonin syndrome (may be life threatening when used with certain other medicines)Increased risk of bleeding problemsSlow growth in childrenSexual problems This medicine may make you dizzy or drowsy. Do not drive or do anything that could be dangerous until you know how this medicine affects you. Do not stop using this medicine suddenly. Your doctor will need to slowly decrease your dose before you stop it completely. Your doctor will do lab tests at regular visits to check on the effects of this medicine. Keep all appointments. Keep all medicine out of the reach of children. Never share your medicine with anyone. Thoughts of hurting yourself or others, unusual behavior Unusual bleeding or bruising
Food Warnings:Do not use this medicine if you are using pimozide. Do not use this medicine together with an MAO inhibitor (MAOI) or if you have used an MAOI within the past 14 days. Do not take an MAOI for at least 14 days after you stop this medicine., Do not drink alcohol while you are using this medicine., This medicine may make you dizzy or drowsy. Do not drive or do anything that could be dangerous until you know how this medicine affects you., Your doctor may want to monitor your child's weight and height, because this medicine may cause decreased appetite and weight loss in children., Some medicines can affect how citalopram works. Tell your doctor if you are using the following: Buspirone, carbamazepine, chlorpromazine, cimetidine, fentanyl, gatifloxacin, imipramine, itraconazole, ketoconazole, levomethadyl, lithium, methadone, meperidine, moxifloxacin, omeprazole, pentamidine, St John's wort, thioridazine, tramadol, tryptophan supplementsAmphetaminesBlood thinner (including warfarin)Diuretic (water pill)Medicine for heart rhythm problems (including amiodarone, procainamide, quinidine, sotalol)NSAID pain or arthritis medicine (including aspirin, celecoxib, diclofenac, ibuprofen, naproxen)Triptan medicine to treat migraine headaches (including sumatriptan), Do not stop using this medicine suddenly. Your doctor will need to slowly decrease your dose before you stop it completely., Your doctor will check your progress and the effects of this medicine at regular visits. Keep all appointments., Keep all medicine out of the reach of children.
Read moreThis product is not intended to be used by women or children. Do not take this medicine if you are pregnant or breastfeeding without consulting your doctor's.
This product is not intended to be used by anyone under the age of 18 years. This medicine is also not intended for use by women or children. This medicine is also not intended to be used by pregnant women or women of childbearing potential. This medicine is also not intended for use by children to treat or prevent any condition other than depression.
We recently published a study that explored the efficacy of selective serotonin reuptake inhibitors (SSRIs) in the management of the condition of depression. We hypothesized that SSRIs would increase the efficacy of Celexa (citalopram) in patients with major depressive disorder (MDD), as well as in those with MDD who do not respond to other treatments for MDD. We also hypothesized that Celexa would be more effective than SSRIs in treating MDD patients who do not respond to other treatments for MDD. Finally, we hypothesized that Celexa would be more effective than SSRIs in treating MDD patients who do not respond to other treatments for MDD.
This randomized, controlled, double-blind, placebo-controlled clinical trial included 692 patients with MDD who were randomized to receive Celexa (citalopram) or placebo in the dose range of 1-20 mg/day. The patients were included in the study if they had a clinical diagnosis of MDD (ie, a first episode of MDD, a clinical diagnosis of MDD in the absence of other treatment options) and were not taking any other medications or had had anorexia nervosa or bulimia. The patients had a mean age of 55.3 years (range: 39 to 75 years). The primary outcome measure was the percentage of patients who were treated with Celexa for 1 year or less. Secondary outcomes included the percentage of patients who discontinued Celexa (defined as the number of patients who discontinued treatment due to the following reasons), the percentage of patients who discontinued Celexa (defined as the number of patients who discontinued treatment due to the following reasons), the proportion of patients who discontinued Celexa after Celexa discontinuation, and the proportion of patients who discontinued Celexa after the second attempt. We also measured the incidence of adverse events, including suicidal thoughts, in patients who discontinued Celexa or the second attempt.
The primary endpoint was the change from baseline in the Hamilton Depression Rating Scale (HAM-D), which is a measure of the severity of depression in patients with MDD. The secondary endpoints were the change from baseline in the Hamilton Anxiety Rating Scale (HAM-A), which is a measure of the severity of anxiety in patients with MDD.
The patients who met the inclusion criteria were randomized to receive either Celexa or the placebo (n=92). This was a double-blind, placebo-controlled, double-dummy, placebo-controlled, double-dose study, designed to mimic the design of the current study, and was designed to recruit patients who meet the following inclusion criteria: 1) at least 50% of patients with MDD and/or a clinical diagnosis of MDD; 2) at least 60% of patients with MDD; 3) at least 60% of patients with MDD who are in remission after an initial remission period, and who were randomized to receive Celexa or placebo; and 4) at least 90% of patients with MDD who are in remission after an initial remission period, and who were randomized to receive Celexa or placebo. We did not recruit patients who were not receiving other treatments for MDD, and we did not recruit patients who did not respond to other treatment options. We also used a validated measure of the Hamilton Rating Scale for Depression (HAM-D) [] to determine patients’ responses to treatment with Celexa. We also measured the incidence of suicidal ideations, self-injurious behavior, and suicidal thoughts/motions (suicidality) among patients who discontinued treatment due to the following reasons: 1) discontinued Celexa; 2) the second attempt; 3) the second attempt due to a second attempt, and 4) the third attempt.
For the trial design, the study was approved by the Institutional Review Board at the University of Wisconsin School of Medicine in an effort to ensure that all patients had an opportunity to participate in the study. We also conducted a post hoc analysis that excluded patients who did not have any additional treatment options. Patients were excluded if they were pregnant, had a history of suicide attempts or attempts in the previous 6 months, or had any history of drug-induced psychiatric disorders, or other serious psychiatric disorders. All patients were evaluated for any psychiatric disorders by a psychiatric provider. We were able to recruit patients for the trial by computer-generated randomization using a stratified computer-generated sequence. We also used a pre-screening process that excluded patients who had a history of suicide attempts or attempts in the previous 12 months. We excluded patients who had a clinical diagnosis of MDD or who had a diagnosis of MDD based on the DSM-IV, or who had a diagnosis of MDD based on the ICD-10-TR and MDD-R.
Celexa 20 mg is a medicine that is used to treat a wide range of mental health conditions like anxiety, depression, and insomnia. It is also used for treating the symptoms of depression and is also available in a tablet form.
Celexa 20 mg is used to treat conditions like anxiety, depression, insomnia, and depression.
Celexa 20 mg works by helping to regulate the levels of certain chemicals in the brain, which may help to improve your condition and symptoms.
Some of the side effects of Celexa 20 mg are nausea, vomiting, dizziness, diarrhoea, and insomnia. These side effects are usually mild and go away on their own with time. However, if you experience any severe or persistent side effects then you should consult your doctor immediately.
It is not recommended to take Celexa 20 mg while pregnant or breastfeeding unless necessary. However, if you are planning to be exposed to the sunlight then there are some precautions to take.
Celexa 20 mg is usually taken as a one pill or extended-release tablet. It can be taken with or without food, however, if you have a stomach or intestinal ulcer then you should not take the medicine without consulting your doctor.
The side effects of Celexa 20 mg are usually mild to moderate in nature and go away with time. However, if they become more severe or persistent, you should speak to your doctor or a pharmacist.
The most common side effects of Celexa 20 mg are:
If you experience any severe or persistent side effects then you should consult your doctor or a pharmacist.
Celexa 20 mg can take effect within 24 hours of taking the drug. However, it can take effects of up to 5 days for it to work. Therefore, if you are taking Celexa 20 mg for anxiety then you should be advised to take it for 4 weeks before taking the drug.
It is not recommended to take Celexa 20 mg while breastfeeding unless necessary.
The aim of this study was to investigate the effect of the antidepressant Celexa and the pharmacological agents, such as duloxetine and amitriptyline, on cGMP-dependent protein kinase A (PK-A) and phosphorylation of cGMP-dependent protein kinase B (PK-B) in the rat corpus cavernosum. The expression of PK-A, PK-B and cGMP-dependent protein kinase A/B was evaluated by immunofluorescence staining. The effects of Celexa and amitriptyline on PK-A, PK-B and cGMP-dependent protein kinase A/B protein kinase A/B phosphorylation in the rat corpus cavernosum were investigated. At the end of 8 weeks, animals were divided into groups by groups and the rats were divided into four groups as follows: group I, group II, group III and group IV. The plasma PK-A, PK-B and cGMP-dependent protein kinase A/B protein kinase A/B phosphorylation was assessed by western blot analysis. At the end of 8 weeks, the rats were treated with Celexa, amitriptyline and duloxetine for 8 weeks. The effects of Celexa, amitriptyline and duloxetine on PK-A, PK-B and cGMP-dependent protein kinase A/B protein kinase A/B phosphorylation in the rat corpus cavernosum were investigated. The plasma PK-A, PK-B and cGMP-dependent protein kinase A/B protein kinase A/B protein kinase A/B phosphorylation was assessed by western blot analysis.
Stade de France Pharmacy